A recent retrospective and integrated genomic, transcriptomic, and protein analysis identified the transcript and protein products of SPAG5 as biomarkers of chemotherapy sensitivity in estrogen receptor-negative BC [72]. The gene discussed is ESR1; the disease is breast cancer.